BAFNAPH — Bafna Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Bafna Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	C2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.1	84.8	18	1.73	78.1
Net Total Accounts Receivable
Net Total Receivables	248	60.3	95.6	155	417
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	485	359	497	509	873
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	370	352	368	388	402
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,195	711	865	901	1,296
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	708	171	243	220	465
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,004	201	297	282	561
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	191	509	568	620	735
Total Liabilities & Shareholders' Equity	1,195	711	865	901	1,296
Total Common Shares Outstanding